Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Baker

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Perceptual and Motor Skills|August 1, 1974
Delinquency and stimulation seeking: re-analysis of Petrie's study of kinesthetic aftereffectsA H Baker, B L Mishara, I W Kostin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous veinA Kranzhöfer, A H Baker, S J George, et al.
Cardiovascular Research|May 30, 2001
Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cellsM Bond, A J Chase, A H Baker, et al.
Cardiovascular Research|January 31, 1998
Prevention of vein graft failure: potential applications for gene therapyA H Baker, D Mehta, S J George, et al.
Journal of Personality and Social Psychology|February 1, 1979
Menstrual cycle affects kinesthetic aftereffect, an index of personality and perceptual styleA H Baker, B L Mishara, I W Kostin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2001
Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse modelY Hu, A H Baker, Y Zou, et al.
Molecular & Cellular Proteomics : MCP|December 1, 2012
Platform dependencies in bottom-up hydrogen/deuterium exchange mass spectrometryKyle M Burns, Martial Rey, Charles A H Baker, et al.
Gene Therapy|June 15, 2001
Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosisS J George, G D Angelini, M C Capogrossi, et al.
Gene Therapy|February 4, 1999
Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veinsS J George, A H Baker, G D Angelini, et al.
Current Gene Therapy|March 23, 2004
Promoters and control elements: designing expression cassettes for gene therapyE D Papadakis, S A Nicklin, A H Baker, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Perceptual and Motor Skills|August 1, 1974
Delinquency and stimulation seeking: re-analysis of Petrie's study of kinesthetic aftereffectsA H Baker, B L Mishara, I W Kostin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous veinA Kranzhöfer, A H Baker, S J George, et al.
Cardiovascular Research|May 30, 2001
Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cellsM Bond, A J Chase, A H Baker, et al.
Cardiovascular Research|January 31, 1998
Prevention of vein graft failure: potential applications for gene therapyA H Baker, D Mehta, S J George, et al.
Journal of Personality and Social Psychology|February 1, 1979
Menstrual cycle affects kinesthetic aftereffect, an index of personality and perceptual styleA H Baker, B L Mishara, I W Kostin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2001
Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse modelY Hu, A H Baker, Y Zou, et al.
Molecular & Cellular Proteomics : MCP|December 1, 2012
Platform dependencies in bottom-up hydrogen/deuterium exchange mass spectrometryKyle M Burns, Martial Rey, Charles A H Baker, et al.
Gene Therapy|June 15, 2001
Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosisS J George, G D Angelini, M C Capogrossi, et al.
Gene Therapy|February 4, 1999
Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veinsS J George, A H Baker, G D Angelini, et al.
Current Gene Therapy|March 23, 2004
Promoters and control elements: designing expression cassettes for gene therapyE D Papadakis, S A Nicklin, A H Baker, et al.
Pageof 10